| KT | Kidney Transplantation |
| OPTN | Organ Procurement and Transplantation Network |
| DM | Diabetes Mellitus |
| USRDS | United States Renal Data System |
| PTDM | Post-transplant diabetes mellitus |
| NODAT | New onset diabetes after transplantation |
| OGTT | Oral glucose tolerance test |
| TAH | Transplant-associated hyperglycemia |
| IFG | Impaired fasting glucose |
| IGT | Impaired glucose tolerance |
| ADA | American Diabetes Association |
| WHO | World Health Organization |
| FPG | Fasting plasma glucose |
| HbA1C | Hemoglobin A1C |
| CV | Cardiovascular |
| GFR | Glomerular Filtration Rate |
| T2DM | Type 2 DM |
| HLA | Human leukocyte antigen |
| GLP-1 | Glucagon-like peptide 1 |
| CNI | Calcineurin inhibitors |
| mTOR | Mammalian target of rapamycin |
| CMV | Cytomegalovirus |
| PPAR | Proliferator-activated receptor |
| DDP-4 | Dipeptidyl Peptidase 4 |
| SGLT2 | Sodium-glucose cotransporter type 2 |
| NSAIDs | Nonsteroidal anti-inflammatory drugs |
| P-gp | P-glycloprotein |
| Nrf2 | Nuclear factor erythroid 2-related factor |
| HO-1 | Heme oxygenase 1 |
| G6PD | Glucose 6 phosphate dehydrogenase |
| TXNRD1 | Thioredoxin reductase 1 |
| DMF | Dimethyl Fumarate |